Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential

Zeguo Zhao, Elena Weinstein, Marina Tuzova, Anne Davidson, Peter Mundel, Paola Marambio, Chaim Putterman

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Objective. Cross-reactivity with kidney antigens is believed to be a critical determinant in the renal pathogenicity of anti-double-stranded DNA (anti-dsDNA) antibodies. Murine nephritogenic anti-dsDNA antibodies have been shown to cross-react with α-actinin, and anti-α-actinin antibodies have been found to be deposited in the kidneys of lupus mice with active nephritis. Furthermore, in humans with systemic lupus erythematosus (SLE), it has been found that a greater proportion of polyclonal IgG anti-dsDNA antibodies from patients with renal involvement bind to α-actinin than do those from patients without renal disease. We undertook this study to substantiate a direct link between cross-reactive anti-dsDNA/anti-α-actinin antibodies and the pathogenesis of lupus nephritis in humans. Methods. A panel of 10 anti-dsDNA and/or anti-α-actinin antibodies was generated by Epstein-Barr virus transformation of lymphocytes from patients with SLE and was extensively characterized. Antibody binding was studied by enzyme-linked immunosorbent assay and Western blotting. Antibody potential for pathogenicity was assessed by measuring binding to isolated glomeruli and mesangial cells and by evaluation of histologic features of the kidney following injection in vivo. Results. All anti-dsDNA antibodies isolated also bound α-actinin. Cross-reactive antibodies bound to mesangial cells and to isolated glomeruli ex vivo. Binding to glomeruli was not inhibited by DNase treatment, but could be abrogated by α-actinin. Furthermore, histopathologic abnormalities seen in mice injected intraperitoneally with a cross-reactive cell line included fusion of podocyte foot processes and subepithelial and subendothelial deposition. Conclusion. These studies provide strong support for the hypothesis that α-actinin is a major cross-reactive target for anti-dsDNA antibodies in SLE patients. Cross-reactive anti-dsDNA/anti-α-actinin anti-bodies from SLE patients are pathogenic and may contribute to the kidney lesions in lupus nephritis.

Original languageEnglish (US)
Pages (from-to)522-530
Number of pages9
JournalArthritis and Rheumatism
Volume52
Issue number2
DOIs
StatePublished - Feb 2005

Fingerprint

Actinin
Anti-Idiotypic Antibodies
Antibodies
Kidney
DNA
Systemic Lupus Erythematosus
Lupus Nephritis
Mesangial Cells
Virulence
Podocytes
Deoxyribonucleases
Nephritis
Lymphocyte Activation
Human Herpesvirus 4
Western Blotting
Enzyme-Linked Immunosorbent Assay
Antigens
Cell Line
Injections

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential. / Zhao, Zeguo; Weinstein, Elena; Tuzova, Marina; Davidson, Anne; Mundel, Peter; Marambio, Paola; Putterman, Chaim.

In: Arthritis and Rheumatism, Vol. 52, No. 2, 02.2005, p. 522-530.

Research output: Contribution to journalArticle

Zhao, Zeguo ; Weinstein, Elena ; Tuzova, Marina ; Davidson, Anne ; Mundel, Peter ; Marambio, Paola ; Putterman, Chaim. / Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential. In: Arthritis and Rheumatism. 2005 ; Vol. 52, No. 2. pp. 522-530.
@article{be0bf7d76144438b81e4e3054d900fb7,
title = "Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential",
abstract = "Objective. Cross-reactivity with kidney antigens is believed to be a critical determinant in the renal pathogenicity of anti-double-stranded DNA (anti-dsDNA) antibodies. Murine nephritogenic anti-dsDNA antibodies have been shown to cross-react with α-actinin, and anti-α-actinin antibodies have been found to be deposited in the kidneys of lupus mice with active nephritis. Furthermore, in humans with systemic lupus erythematosus (SLE), it has been found that a greater proportion of polyclonal IgG anti-dsDNA antibodies from patients with renal involvement bind to α-actinin than do those from patients without renal disease. We undertook this study to substantiate a direct link between cross-reactive anti-dsDNA/anti-α-actinin antibodies and the pathogenesis of lupus nephritis in humans. Methods. A panel of 10 anti-dsDNA and/or anti-α-actinin antibodies was generated by Epstein-Barr virus transformation of lymphocytes from patients with SLE and was extensively characterized. Antibody binding was studied by enzyme-linked immunosorbent assay and Western blotting. Antibody potential for pathogenicity was assessed by measuring binding to isolated glomeruli and mesangial cells and by evaluation of histologic features of the kidney following injection in vivo. Results. All anti-dsDNA antibodies isolated also bound α-actinin. Cross-reactive antibodies bound to mesangial cells and to isolated glomeruli ex vivo. Binding to glomeruli was not inhibited by DNase treatment, but could be abrogated by α-actinin. Furthermore, histopathologic abnormalities seen in mice injected intraperitoneally with a cross-reactive cell line included fusion of podocyte foot processes and subepithelial and subendothelial deposition. Conclusion. These studies provide strong support for the hypothesis that α-actinin is a major cross-reactive target for anti-dsDNA antibodies in SLE patients. Cross-reactive anti-dsDNA/anti-α-actinin anti-bodies from SLE patients are pathogenic and may contribute to the kidney lesions in lupus nephritis.",
author = "Zeguo Zhao and Elena Weinstein and Marina Tuzova and Anne Davidson and Peter Mundel and Paola Marambio and Chaim Putterman",
year = "2005",
month = "2",
doi = "10.1002/art.20862",
language = "English (US)",
volume = "52",
pages = "522--530",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential

AU - Zhao, Zeguo

AU - Weinstein, Elena

AU - Tuzova, Marina

AU - Davidson, Anne

AU - Mundel, Peter

AU - Marambio, Paola

AU - Putterman, Chaim

PY - 2005/2

Y1 - 2005/2

N2 - Objective. Cross-reactivity with kidney antigens is believed to be a critical determinant in the renal pathogenicity of anti-double-stranded DNA (anti-dsDNA) antibodies. Murine nephritogenic anti-dsDNA antibodies have been shown to cross-react with α-actinin, and anti-α-actinin antibodies have been found to be deposited in the kidneys of lupus mice with active nephritis. Furthermore, in humans with systemic lupus erythematosus (SLE), it has been found that a greater proportion of polyclonal IgG anti-dsDNA antibodies from patients with renal involvement bind to α-actinin than do those from patients without renal disease. We undertook this study to substantiate a direct link between cross-reactive anti-dsDNA/anti-α-actinin antibodies and the pathogenesis of lupus nephritis in humans. Methods. A panel of 10 anti-dsDNA and/or anti-α-actinin antibodies was generated by Epstein-Barr virus transformation of lymphocytes from patients with SLE and was extensively characterized. Antibody binding was studied by enzyme-linked immunosorbent assay and Western blotting. Antibody potential for pathogenicity was assessed by measuring binding to isolated glomeruli and mesangial cells and by evaluation of histologic features of the kidney following injection in vivo. Results. All anti-dsDNA antibodies isolated also bound α-actinin. Cross-reactive antibodies bound to mesangial cells and to isolated glomeruli ex vivo. Binding to glomeruli was not inhibited by DNase treatment, but could be abrogated by α-actinin. Furthermore, histopathologic abnormalities seen in mice injected intraperitoneally with a cross-reactive cell line included fusion of podocyte foot processes and subepithelial and subendothelial deposition. Conclusion. These studies provide strong support for the hypothesis that α-actinin is a major cross-reactive target for anti-dsDNA antibodies in SLE patients. Cross-reactive anti-dsDNA/anti-α-actinin anti-bodies from SLE patients are pathogenic and may contribute to the kidney lesions in lupus nephritis.

AB - Objective. Cross-reactivity with kidney antigens is believed to be a critical determinant in the renal pathogenicity of anti-double-stranded DNA (anti-dsDNA) antibodies. Murine nephritogenic anti-dsDNA antibodies have been shown to cross-react with α-actinin, and anti-α-actinin antibodies have been found to be deposited in the kidneys of lupus mice with active nephritis. Furthermore, in humans with systemic lupus erythematosus (SLE), it has been found that a greater proportion of polyclonal IgG anti-dsDNA antibodies from patients with renal involvement bind to α-actinin than do those from patients without renal disease. We undertook this study to substantiate a direct link between cross-reactive anti-dsDNA/anti-α-actinin antibodies and the pathogenesis of lupus nephritis in humans. Methods. A panel of 10 anti-dsDNA and/or anti-α-actinin antibodies was generated by Epstein-Barr virus transformation of lymphocytes from patients with SLE and was extensively characterized. Antibody binding was studied by enzyme-linked immunosorbent assay and Western blotting. Antibody potential for pathogenicity was assessed by measuring binding to isolated glomeruli and mesangial cells and by evaluation of histologic features of the kidney following injection in vivo. Results. All anti-dsDNA antibodies isolated also bound α-actinin. Cross-reactive antibodies bound to mesangial cells and to isolated glomeruli ex vivo. Binding to glomeruli was not inhibited by DNase treatment, but could be abrogated by α-actinin. Furthermore, histopathologic abnormalities seen in mice injected intraperitoneally with a cross-reactive cell line included fusion of podocyte foot processes and subepithelial and subendothelial deposition. Conclusion. These studies provide strong support for the hypothesis that α-actinin is a major cross-reactive target for anti-dsDNA antibodies in SLE patients. Cross-reactive anti-dsDNA/anti-α-actinin anti-bodies from SLE patients are pathogenic and may contribute to the kidney lesions in lupus nephritis.

UR - http://www.scopus.com/inward/record.url?scp=13444270344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444270344&partnerID=8YFLogxK

U2 - 10.1002/art.20862

DO - 10.1002/art.20862

M3 - Article

C2 - 15693007

AN - SCOPUS:13444270344

VL - 52

SP - 522

EP - 530

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 2

ER -